Prime in rheumatology: Obstacles to paid household go away; dangers of B-cell depleting therapies

September 02, 2022

1 min learn


The usual 12 weeks of paid household go away in the US is commonly unavailable to well being care suppliers. For them, the truth of paid go away is way completely different, consultants mentioned.

The stigma and obstacles that nurses and physicians face when attempting to take paid household go away could be tough to beat. It was the highest story in rheumatology final week.

BreastMilkPump2
Supply: Adobe Inventory

One other high story coated the affiliation of B-cell depleting brokers with decreased antibody responses to SARS-CoV-2 vaccination.

Learn these and extra high tales in rheumatology beneath:

Well being care business struggles to maintain tempo with ‘tectonic shift’ in paid household go away

For a rising variety of Individuals, 12 weeks of paid go away from work after the delivery of a kid, or to take care of an ailing member of the family, is customary. For a lot of well being care suppliers, together with physicians and nurses, the truth of paid go away is way completely different. Read more.

B-cell depleting therapies ‘greatest risk’ for decreased SARS-CoV-2 mRNA vaccine response

B-cell depleting brokers, glucocorticoids and mycophenolate mofetil have all been related to decreased antibody responses to SARS-CoV-2 vaccination, famous a presenter on the 2022 Affiliation of Girls in Rheumatology Annual Convention. Read more.

FDA approves citrate-free, excessive focus formulation of Humira biosimilar

The FDA has permitted a citrate-free, 100 mg/mL formulation of the Humira biosimilar Hadlima, based on a press release launched by Samsung Bioepis and Organon. Read more.

Immune-related adversarial occasions current ‘double-edged sword,’ want multidisciplinary enter

Though oncologists take the lead in most cancers administration with immunotherapies, rheumatologist enter is crucial to managing the following immune-related adversarial occasions, which pose challenges to coordinated affected person care. Read more.

‘Consolation stage’ driving divide between rheumatologists, nephrologists in lupus nephritis

Latest knowledge has revealed a rising divide between rheumatologists and nephrologists of their therapeutic decisions for sufferers with lupus nephritis, based on researchers from Spherix World Insights. Read more.

Share

Leave a Reply